In Situ Deployment of Engineered Extracellular Vesicles into the Tumor Niche via Myeloid-Derived Suppressor Cells
Extracellular vesicles (EVs) have emerged as a promising carrier system for the delivery of therapeutic payloads in multiple disease models, including cancer. However, effective targeting of EVs to cancerous tissue remains a challenge. Here, it is shown that nonviral transfection of myeloid-derived...
Saved in:
Published in | Advanced healthcare materials Vol. 11; no. 5; p. e2101619 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
01.03.2022
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Extracellular vesicles (EVs) have emerged as a promising carrier system for the delivery of therapeutic payloads in multiple disease models, including cancer. However, effective targeting of EVs to cancerous tissue remains a challenge. Here, it is shown that nonviral transfection of myeloid-derived suppressor cells (MDSCs) can be leveraged to drive targeted release of engineered EVs that can modulate transfer and overexpression of therapeutic anticancer genes in tumor cells and tissue. MDSCs are immature immune cells that exhibit enhanced tropism toward tumor tissue and play a role in modulating tumor progression. Current MDSC research has been mostly focused on mitigating immunosuppression in the tumor niche; however, the tumor homing abilities of these cells present untapped potential to deliver EV therapeutics directly to cancerous tissue. In vivo and ex vivo studies with murine models of breast cancer show that nonviral transfection of MDSCs does not hinder their ability to home to cancerous tissue. Moreover, transfected MDSCs can release engineered EVs and mediate antitumoral responses via paracrine signaling, including decreased invasion/metastatic activity and increased apoptosis/necrosis. Altogether, these findings indicate that MDSCs can be a powerful tool for the deployment of EV-based therapeutics to tumor tissue. |
---|---|
AbstractList | Extracellular vesicles (EVs) have emerged as a promising carrier system for the delivery of therapeutic payloads in multiple disease models, including cancer. However, effective targeting of EVs to cancerous tissue remains a challenge. Here, it is shown that nonviral transfection of myeloid-derived suppressor cells (MDSCs) can be leveraged to drive targeted release of engineered EVs that can modulate transfer and overexpression of therapeutic anticancer genes in tumor cells and tissue. MDSCs are immature immune cells that exhibit enhanced tropism toward tumor tissue and play a role in modulating tumor progression. Current MDSC research has been mostly focused on mitigating immunosuppression in the tumor niche; however, the tumor homing abilities of these cells present untapped potential to deliver EV therapeutics directly to cancerous tissue. In vivo and ex vivo studies with murine models of breast cancer show that nonviral transfection of MDSCs does not hinder their ability to home to cancerous tissue. Moreover, transfected MDSCs can release engineered EVs and mediate antitumoral responses via paracrine signaling, including decreased invasion/metastatic activity and increased apoptosis/necrosis. Altogether, these findings indicate that MDSCs can be a powerful tool for the deployment of EV-based therapeutics to tumor tissue. |
Author | Lawrence, William R Carson, William E Turaga, Rithvik Duarte-Sanmiguel, Silvia McCoy, William Gallego-Perez, Daniel Dodd, Daniel J Moore, Jordan T Panic, Ana Zachariah, Natalie Skardal, Aleksander Nairon, Kylie Francis, Carlie Salazar-Puerta, Ana Higuita-Castro, Natalia |
Author_xml | – sequence: 1 givenname: Silvia orcidid: 0000-0002-1171-8945 surname: Duarte-Sanmiguel fullname: Duarte-Sanmiguel, Silvia organization: Department of Biomedical Engineering, The Ohio State University, Columbus, OH, 43210, USA – sequence: 2 givenname: Ana orcidid: 0000-0002-7874-9965 surname: Panic fullname: Panic, Ana organization: Department of Biomedical Engineering, The Ohio State University, Columbus, OH, 43210, USA – sequence: 3 givenname: Daniel J orcidid: 0000-0003-4095-053X surname: Dodd fullname: Dodd, Daniel J organization: Biomedical Sciences Graduate Program, The Ohio State University, Columbus, OH, 43210, USA – sequence: 4 givenname: Ana orcidid: 0000-0003-4954-6226 surname: Salazar-Puerta fullname: Salazar-Puerta, Ana organization: Department of Biomedical Engineering, The Ohio State University, Columbus, OH, 43210, USA – sequence: 5 givenname: Jordan T orcidid: 0000-0002-6391-8471 surname: Moore fullname: Moore, Jordan T organization: Department of Biomedical Engineering, The Ohio State University, Columbus, OH, 43210, USA – sequence: 6 givenname: William R orcidid: 0000-0001-8639-3420 surname: Lawrence fullname: Lawrence, William R organization: Biomedical Sciences Graduate Program, The Ohio State University, Columbus, OH, 43210, USA – sequence: 7 givenname: Kylie surname: Nairon fullname: Nairon, Kylie organization: Department of Biomedical Engineering, The Ohio State University, Columbus, OH, 43210, USA – sequence: 8 givenname: Carlie surname: Francis fullname: Francis, Carlie organization: Department of Biomedical Engineering, The Ohio State University, Columbus, OH, 43210, USA – sequence: 9 givenname: Natalie surname: Zachariah fullname: Zachariah, Natalie organization: Department of Biomedical Engineering, The Ohio State University, Columbus, OH, 43210, USA – sequence: 10 givenname: William surname: McCoy fullname: McCoy, William organization: Department of Biomedical Engineering, The Ohio State University, Columbus, OH, 43210, USA – sequence: 11 givenname: Rithvik surname: Turaga fullname: Turaga, Rithvik organization: Department of Biomedical Engineering, The Ohio State University, Columbus, OH, 43210, USA – sequence: 12 givenname: Aleksander surname: Skardal fullname: Skardal, Aleksander organization: Department of Biomedical Engineering, The Ohio State University, Columbus, OH, 43210, USA – sequence: 13 givenname: William E surname: Carson fullname: Carson, William E organization: Department of Surgery, The Ohio State University, Columbus, OH, 43210, USA – sequence: 14 givenname: Natalia surname: Higuita-Castro fullname: Higuita-Castro, Natalia organization: Biophysics Program, The Ohio State University, Columbus, OH, 43210, USA – sequence: 15 givenname: Daniel orcidid: 0000-0002-6263-3191 surname: Gallego-Perez fullname: Gallego-Perez, Daniel organization: Department of Surgery, The Ohio State University, Columbus, OH, 43210, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34662497$$D View this record in MEDLINE/PubMed |
BookMark | eNo1jz1PwzAYhC0EoqV0ZUT-Ayn-imOPqC1QqcDQwlo5zhtq5HxgJxX590QCbrkb7h7prtB53dSA0A0lC0oIuzPFsVowwiihkuozNGVUs4TJVE_QPMZPMkqmVCp6iSZcSMmEzqboa1Pjnet6vILWN0MFdYebEq_rD1cDBCjw-rsLxoL3vTcBv0N01kPEru4a3B0B7_uqCfjF2TGfnMHPA_jGFckKgjuN-13ftgFiHEvLkRKv0UVpfIT5n8_Q28N6v3xKtq-Pm-X9NrFCKp2wVEhOMmu5NnmRcWOK1GgQWvOSC0Jzk5VCGZIrmXErU6kkz8vUCDUe04qzGbr95bZ9XkFxaIOrTBgO_9_ZD12FXMw |
CitedBy_id | crossref_primary_10_1016_j_addr_2023_115028 crossref_primary_10_1002_adma_202201054 crossref_primary_10_1039_D3BM00573A crossref_primary_10_1002_adma_202210579 crossref_primary_10_1002_adtp_202200255 crossref_primary_10_1208_s12248_022_00692_3 crossref_primary_10_1002_adtp_202200197 crossref_primary_10_1002_adhm_202301010 crossref_primary_10_1002_anbr_202200173 crossref_primary_10_1007_s13770_022_00503_y crossref_primary_10_3389_fimmu_2024_1363185 |
ContentType | Journal Article |
Copyright | 2021 Wiley-VCH GmbH. |
Copyright_xml | – notice: 2021 Wiley-VCH GmbH. |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1002/adhm.202101619 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Engineering |
EISSN | 2192-2659 |
ExternalDocumentID | 34662497 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIDDK NIH HHS grantid: DP1 DK126199 – fundername: NIDDK NIH HHS grantid: P30 DK020572 – fundername: NIBIB NIH HHS grantid: DP2 EB028110 |
GroupedDBID | 05W 0R~ 1OC 31~ 33P 53G 8-0 8-1 A00 AAESR AAHHS AAIHA AANLZ AASGY AAXRX AAZKR ABCUV ABLJU ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACIWK ACPOU ACPRK ACXBN ACXQS ADBBV ADBTR ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AENEX AEQDE AEUYR AFBPY AFFPM AFGKR AFRAH AFZJQ AHBTC AHMBA AIACR AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMYDB ASPBG AVWKF AZFZN AZVAB BDRZF BFHJK BMXJE BRXPI C45 CGR CUY CVF D-A D-B DCZOG DRFUL DRMAN DRSTM EBD EBS ECM EIF EJD EMOBN G-S GODZA HGLYW HZ~ KBYEO LATKE LEEKS LITHE LOXES LUTES LYRES MEWTI MXFUL MXMAN MXSTM MY. MY~ NPM O9- OVD P2W PQQKQ ROL SUPJJ SV3 TEORI WBKPD WOHZO WXSBR WYJ ZZTAW |
ID | FETCH-LOGICAL-c4689-2546307cc39abd73aad5a9e4993f3401ba7f48a0b8673c656863bf5a482499832 |
IngestDate | Thu May 23 23:30:32 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | tumor tropism extracellular vesicles nonviral gene and cell therapies myeloid-derived suppressor cells solid tumors |
Language | English |
License | 2021 Wiley-VCH GmbH. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4689-2546307cc39abd73aad5a9e4993f3401ba7f48a0b8673c656863bf5a482499832 |
ORCID | 0000-0002-7874-9965 0000-0002-1171-8945 0000-0003-4095-053X 0000-0002-6391-8471 0000-0003-4954-6226 0000-0002-6263-3191 0000-0001-8639-3420 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891033 |
PMID | 34662497 |
ParticipantIDs | pubmed_primary_34662497 |
PublicationCentury | 2000 |
PublicationDate | 2022-03-01 |
PublicationDateYYYYMMDD | 2022-03-01 |
PublicationDate_xml | – month: 03 year: 2022 text: 2022-03-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany |
PublicationTitle | Advanced healthcare materials |
PublicationTitleAlternate | Adv Healthc Mater |
PublicationYear | 2022 |
SSID | ssj0000651681 |
Score | 2.3795629 |
Snippet | Extracellular vesicles (EVs) have emerged as a promising carrier system for the delivery of therapeutic payloads in multiple disease models, including cancer.... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | e2101619 |
SubjectTerms | Animals Breast Neoplasms - therapy Extracellular Vesicles Female Humans Mice Myeloid-Derived Suppressor Cells Tumor Microenvironment |
Title | In Situ Deployment of Engineered Extracellular Vesicles into the Tumor Niche via Myeloid-Derived Suppressor Cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34662497 |
Volume | 11 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9sgFEbpJk3dw7T7upt42NvkzjEY8GPVdWontarUdOpbBRhWS4mTpXHU9R_tX-4AJnazTru8WBbYls33cTgHfxwQepeW1mZg5hLKBHFbmHHoUikAwrWlMrWU--Vih0ds_5R-PsvPBoMfPdVSs1Db-vrWdSX_gyqUAa5ulew_ILt6KBTAOeALR0AYjn-F8QH0zWrRgNFw2_bG3_oxxSC4kntXi7l0c_NebPrFXHoRnMsRETzOUTOZzh0b4HxZyfeH3814WpXJR3j7pXNFm5kXysJFu_CUy74ruxPVAxedhAzc3_DdnX_sNKPJiawn1dcmKAJOqvGyWo0Gx7KudJBWrsrcru_d-vfenys5ltdynhw3TkLQv6mdt4CQdyXc2jbevoGtzJKMtQnBozEe9kiX9yyrydw8QzCvv5j9kEZWlhcut8AtFwJss4knAaGMQcTJ_1y7loY7Vm2gDS6cKT1qp4XCkJ8PmRjGpKBp9uHmu2yie_H-tfDFuzGjh-hBG3_gnUCmR2hg6sfofi8r5RP07aDGjla4oxWeWtzRCt-gFY60wo5WGGiFPa2wpxUGqPEarXBHK-xp9RSdftob7e4n7c4ciYY-XSR-E4WUa00KqUpOpCxzWRiInoklELEryS0VMlWCcaIhZBCMKJtLKqAJChhEnqE79bQ2LxCWgoBPbyBsJZrSUqgiN1pppUpjmcz1Fnoe2ut8FtKvnMeWfPnbmldos2Pca3TXAu_NG3AeF-qtB-4n7lxxaA |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+Situ+Deployment+of+Engineered+Extracellular+Vesicles+into+the+Tumor+Niche+via+Myeloid-Derived+Suppressor+Cells&rft.jtitle=Advanced+healthcare+materials&rft.au=Duarte-Sanmiguel%2C+Silvia&rft.au=Panic%2C+Ana&rft.au=Dodd%2C+Daniel+J&rft.au=Salazar-Puerta%2C+Ana&rft.date=2022-03-01&rft.eissn=2192-2659&rft.volume=11&rft.issue=5&rft.spage=e2101619&rft_id=info:doi/10.1002%2Fadhm.202101619&rft_id=info%3Apmid%2F34662497&rft_id=info%3Apmid%2F34662497&rft.externalDocID=34662497 |